Condensed Consolidated Statements Of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Total revenues
Operating expenses:
Research and development	62,154	47,929
General and administrative	16,182	9,658
Total operating expenses	78,336	57,587
Loss from operations	(78,336)	(57,587)
Interest income	3,776	69
Interest expense	(2,336)	0
Net loss	$ (76,896)	$ (57,518)
Net loss per common share:
Basic net loss per common share	$ (4.23)	$ (3.36)
Diluted net loss per common share	$ (4.23)	$ (3.36)
Basic weighted average number of common shares outstanding	18,187,924	17,103,395
Diluted weighted average number of common shares outstanding	18,187,924	17,103,395